Guidelines Development Group

The objective of the Guidelines Development Group (GDG) is to develop evidence-based European Guidelines for breast cancer screening and diagnosis for screening and diagnosis.

The GDG will follow the GRADE approach in defining the healthcare question of interest (population of interest, interventions to be compared and patient-relevant outcomes- PICO), synthesizing the evidence and developing the recommendations for the Guidelines. This will be carried out within virtual working environments and in meetings organised every three months.

An external contractor, CCIb –Iberoamerican Cochrane Centre, supports the GDG for their tasks from literature review to drafting of recommendations.

Members and external experts

Markus Follmann

Markus Follmann

GDG vice-chair of methodology

Markus has a background in medicine. He is a board certified dermatologist and he holds Master degrees in Public Health and Epidemiology. He was trained in Bonn and Berlin, Germany and Rotterdam, the Netherlands.

Working in private practice in dermatology and allergology he additionally followed in 1998 a post doc as methodologist in the field of epidemiology at the Institute for Pharmacoepidemiology and Technology Assessment and in 2002 at the Global Medical Safety Surveillance of Schering AG.

In 2004 he worked as guideline-methodologist at the Division of Evidence based medicine developing the first German evidence based guideline in dermatology. In 2005 he started working as a scientist at the new founded German Institute for Quality and Efficiency in Health Care (IQWiG) and was deputy head of the department guidelines and DMP. Representing IQWiG Markus participated in the EU project “CoCanCPG” under the ERA-NET program which intended to harmonize guideline development processes all over Europe.  

Currently he holds the position of head of the department Evidence based Medicine and Guidelines at the German Cancer Society. Additionally, he is coordinator for the German Guideline Project in Oncology which fosters and funds guideline development, implementation and evaluation in German oncology being launched in 2008. In this position he supports the guideline groups and teaches evidence based medicine and guideline methodology. His position includes supervising the quality indicator developing and implementing process in close cooperation with the certification system of the German Cancer Society and the clinical cancer registries. These QI are the base for guideline implementation and evaluation.

Markus is a board member of the German Network for Evidence based medicine and is speaker of the department guidelines.

Declaration of interests